08:00 , Jan 6, 2014 |  BC Week In Review  |  Company News

Melmed Holdings, Uluru sales and marketing update

On Dec. 18, 2013, Uluru and Altrazeal AG (formerly Altrazeal Trading Ltd.) added rights in India to an expanded 2012 deal granting Altrazeal AG exclusive rights to commercialize antimicrobial dressing Altrazeal in the EU, Australia,...
07:00 , Sep 23, 2013 |  BC Week In Review  |  Company News

Melmed Holdings, Uluru sales and marketing update

Uluru and Altrazeal AG, an entity of Melmed, added rights in Latin America, the Commonwealth of Independent States (CIS) and markets not already licensed in Africa to a 2012 deal granting Altrazeal AG (formerly Altrazeal...
07:00 , Oct 1, 2012 |  BC Week In Review  |  Company News

Melmed Holdings, Uluru deal

Uluru signed a binding term sheet to grant Melmed worldwide rights to commercialize Uluru's OraDisc transmucosal erodible film delivery technology for oral and dental applications. Uluru will have a 25% stake in a subsidiary that...
07:00 , Oct 1, 2012 |  BC Week In Review  |  Company News

Melmed Holdings, Uluru sales and marketing update

Uluru said Melmed's Altrazeal Trading Ltd. subsidiary will launch Altrazeal in Austria this month. Uluru expects the product to launch in additional EU markets early next year. Melmed's subsidiary has exclusive rights to commercialize Altrazeal...
08:00 , Jan 23, 2012 |  BC Week In Review  |  Company News

Melmed Holdings, Uluru sales and marketing update

Uluru finalized a deal granting Melmed's Altrazeal Trading Ltd. subsidiary exclusive rights to commercialize Altrazeal in the EU, Australia, New Zealand, North Africa and the Middle East. Uluru will receive $250,000 in licensing fees and...